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Central nervous system tuberculosis (TB) was identi-
ﬁ  ed in 20 cases of unexplained encephalitis referred to the 
California Encephalitis Project. Atypical features (encepha-
litic symptoms, rapid onset, age) and diagnostic challenges 
(insensitive cerebrospinal ﬂ  uid [CSF] TB PCR result, elevat-
ed CSF glucose levels in patients with diabetes, negative 
result for tuberculin skin test) complicated diagnosis.
T
uberculosis (TB) of the central nervous system (CNS) 
is classically described as meningitis. However, al-
tered mental status, including encephalitis, is within the 
spectrum of clinical manifestations. Because early treat-
ment can dramatically improve outcomes, consideration of 
TB as a potential pathogen in CNS infections, including 
encephalitis, is vital. The California Encephalitis Project 
(CEP), initiated in 1998 to study the causative agents, epi-
demiology, and clinical features of encephalitis, has identi-
ﬁ  ed 20 cases of culture-conﬁ  rmed tuberculous encephalitis. 
In most instances, TB was not initially considered to be a 
likely cause.
The Study
Referrals are received by the CEP statewide from cli-
nicians seeking diagnostic testing for immunocompetent 
patients, including TB PCR testing when appropriate, who 
meet the CEP case deﬁ  nition of encephalitis (1). Myco-
bacterial testing was often also conducted by the referring 
hospital. Inclusion criteria for this report were a positive 
cerebrospinal ﬂ  uid (CSF) culture for Mycobacterium tuber-
culosis complex or a positive CSF TB PCR result. Clinical 
data were compiled from case history forms and other med-
ical records when available. To evaluate differences among 
causes of encephalitis, TB patients were compared with 
CEP patients with cases of enterovirus and herpes simplex 
virus 1 (HSV-1) encephalitis. Demographic, clinical, and 
laboratory data were compared by using the Fisher exact 
test, χ2 test, or Kruskal-Wallis test as appropriate (statistical 
signiﬁ  cance was set at α = 0.05).
From June 1998 through October 2005, a total of 1,587 
patients were enrolled in the CEP; 20 patients fulﬁ  lled cri-
teria as TB cases. Demographic and clinical information 
for the study population are detailed in the online Appen-
dix Table (available from www.cdc.gov/EID/content/14/9/
1473-appT.htm). Median age was 41 years (range 8 months 
to 77 years). The median time from symptom onset to ﬁ  rst 
lumbar puncture was 5 days (range 0–62 days). Seventeen 
patients (85%) had a second lumber puncture.
In general, CSF values became more abnormal over 
time, with increasing leukocyte counts and protein levels 
and decreasing glucose levels (Appendix Table). Most 
patients had a CSF mononuclear cell predominance, al-
though 4 patients (21%) had a neutrophil predominance. 
All patients had cranial neuroimaging, magnetic resonance 
imaging (18 of 20), and computed tomography (20 of 20) 
(Appendix Table; Table). Results of computed tomography 
scans were often normal (50%).
Of patients in whom the results of a recent tuberculin 
skin test (TST) were known, 59% (10 of 17) had a negative 
result (Appendix Table). Many chest radiographs (9 of 18, 
50%) showed no abnormalities. Concurrent culture posi-
tive pulmonary disease was found in 4 (50%) of 8 patients 
tested. A history of foreign birth (53%) or foreign travel 
(80%) was common. When these factors were reported, 5 
patients (25%) had a history of treatment for TB and 5 pa-
tients (63%) had contact with a known case of TB. Only 2 
patients did not have at least 1 of these risk factors.
Of the 20 cases identiﬁ  ed, all had a positive CSF cul-
ture for M. tuberculosis complex. Only 4 (24%) of 17 were 
CSF TB PCR positive and none had a positive CSF acid-
fast bacilli smear (Appendix Table). All but 3 patients had 
pan-susceptible M. tuberculosis isolates; 2 patients had M. 
bovis isolates (resistant to pyrazinamide) and 1 patient had 
an isoniazid-resistant isolate.
When patients with TB were compared with patients 
with viral causes of encephalitis (Table), those with en-
terovirus encephalitis were signiﬁ  cantly younger, were less 
likely to require intensive care, had shorter hospitalizations, 
had fewer abnormal results for CSF and neuroimaging, and 
were less likely to die (all p<0.05). Patients with HSV-1 
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encephalitis were more likely than those with CNS TB to 
be white and non-Hispanic and to have shorter hospital 
stays, lower CSF leukocyte and protein levels, and higher 
CSF glucose levels.
Conclusions
Although tuberculous meningitis is well described, 
prominent encephalitic features are less commonly report-
ed. Illness and death associated with neurotuberculosis are 
highly dependent on the stage of disease at diagnosis; early 
diagnosis and treatment correlates with better outcomes 
(2). Although the TB cases reported here represent only a 
small percentage of CEP cases (<1%), CNS TB with an 
encephalitic picture warrants further discussion because of 
high morbidity and mortality rates and need for early diag-
nosis and appropriate treatment.
This study found atypical features of CNS disease that 
may have confounded early diagnosis. Tuberculous CNS 
disease is typically described as a chronic meningitis with 
insidious onset in children <5 years of age or in older adults 
with relatively few cases during school age years or adoles-
cence (3). In contrast, CEP TB patients came to a hospital 
within 2 weeks of symptom onset and the greatest percent-
age of CEP TB patients was found in persons 10–19 years 
of age (22%).
Although typical CSF studies (mononuclear cell 
pleocytosis, low glucose levels, and elevated protein lev-
els) (4) were often found in CEP CNS TB patients, atypi-
cal ﬁ  ndings were noted. CSF glucose levels were often 
normal in patients with diabetes, although the ratio of 
CSF to serum glucose was invariably low. Additionally, 
a CSF neutrophil predominance was found in 4 patients, 
erroneously suggesting pyogenic meningitis. Although 
clinicians may be tempted to ascribe abnormal CSF val-
ues to viral meningitis or encephalitis based on abnormal 
CSF values, CEP patients with enterovirus and HSV-1 
encephalitis rarely had glucose levels <40 mg/dL. Median 
protein levels were signiﬁ  cantly higher in patients with 
CNS tuberculosis (174 mg/dL in TB) than in patients in-
fected with HSV-1 (71 mg/dL) or enterovirus (60 mg/dL) 
(p<0.001).
Diagnostically, the low sensitivity of CSF TB PCR is 
problematic. Potential explanations for the lack of sensitiv-
ity in CSF specimens include low bacillary load in CSF, 
small sample volumes, and PCR inhibitors in the sample 
(5). Given that all of our patients had positive CSF cul-
tures, we would have expected a higher PCR yield. Most 
concerning was the ﬁ  nding that many providers caring for 
these patients were dissuaded from pursuing TB as a diag-
nostic possibility when the PCR result was negative.
Table. Comparison of TB encephalitis with viral encephalitis, California Encephalitis Project* 
Characteristic CNS  TB  HSV-1  Enterovirus 
Total no. cases   20  39  44 
Patient  demographics     
  Male, no. (%)  12 (60)  14 (36)  25 (57) 
  Median age, y (range)  41 (8 mo–77y)  55 (8 mo–89 y)  13 (6 mo–74 y)† 
  Race white, non-Hispanic, no. (%)  3 (15)  22 (69)‡  14 (33) 
Clinical data       
  Interval from CNS onset to admission, d, median (range)  5 (0–62)  2 (0–28)  2 (0–18)† 
  ICU care, no (%)  15 (75)  19 (56)  20 (53) 
  Fever, no. (%)  15 (75)  35 (92)  35 (80) 
  Seizures, no. (%)  7 (35)  22 (58)  12 (27) 
  Altered consciousness, no. (%)  13 (65)  30 (79)  20 (50) 
  Personality change, no. (%)  9 (45)  17 (45)  7 (17)† 
  Hallucinations, no. (%)  3 (16)  7 (21)  3 (7) 
  Stiff neck, no. (%)  14 (70)  12 (32)§  19 (44) 
  Ataxia, no. (%)  7 (37)  6 (23)  11 (28) 
  Length of hospital stay, d, median (range)  30 (8–753)  15 (0–738)§  6 (0–1,124)¶ 
Laboratory results       
  CSF leukocytes, per mL, median (range)  201 (42–2,845)  47 (0–975)‡  85 (0–1,080)† 
  CSF protein, mg/dL, median (range)  174 (66–357)  71 (15–297)‡  60 (19–881)¶ 
  CSF glucose, mg/dL, median (range)  35 (9–132)  69 (39–112)‡  67 (38–159)¶ 
MRI/CT (abnormal, initial study), no. (%)  17 (85)  36 (95)  12 (39)¶ 
Inpatient deaths, no. (%)  6 (30)  8 (21)  4 (9)† 
*CNS, central nervous system; TB, tuberculosis (Mycobacterium tuberculosis); HSV-1, herpes simplex virus 1; ICU, intensive care unit; CSF, 
cerebrospinal fluid; MRI, magnetic resonance imaging; CT, computed tomography. Denominators may vary slightly depending on available data. Data 
were analyzed (2-way analysis) by using Fisher exact test, Ȥ
2 test, or Kruskal-Wallis test as appropriate, with statistical significance set at Į = 0.05. 
Comparisons without a symbol did not reach statistical significance. 
†CNS TB vs. enterovirus, p<0.05. 
‡CNS TB vs. HSV-1, p<0.001. 
§CNS TB vs. HSV-1, p<0.05. 
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Given the difﬁ  culties in obtaining a rapid diagnosis, 
therapy must often be initiated empirically. Unfortunately, 
a history of TB and TST or chest radiograph results were not 
reliable indicators of active disease and might be difﬁ  cult 
to obtain. Further complicating therapy, lengthy cultures, 
and isolate sensitivities are necessary to optimize choices 
of antimicrobial drugs. Ten percent (2) of our patients were 
infected with M. bovis, a relatively higher percentage than 
in other reports (6–8). Intrinsic pyrazinamide resistance (9) 
of M. bovis required modiﬁ  cation of use of empiric antimi-
crobial drugs.
A limitation of this series is inclusion of only patients 
with a positive CSF culture. Because historical data suggest 
that only 25%–70% of patients with a diagnosis of CNS TB 
have a diagnosis conﬁ  rmed by microbiologic testing (2), 
there were likely additional CEP patients with CNS tuber-
culous disease without a positive acid-fast bacilli culture 
who were not included in this series. Additionally, the se-
ries was limited by the referral bias inherent in the project; 
CEP patients are typically sicker and present greater diag-
nostic challenges. Thus, those with obvious or mild CNS 
tuberculous disease would be underrepresented. Despite 
this potential bias, outcomes were similar (mortality rate 
30%) compared with reported mortality rates (18%–72%) 
and morbidity rates (16%–48%) in previous studies (10).
This report emphasizes some atypical features of CNS 
TB manifested as encephalitis. Encephalopathic changes, 
a relatively rapid course, nonclassic age distribution, and 
negative TB PCR and TST results should not dissuade a cli-
nician from considering TB, particularly when CSF:serum 
glucose ratio (11) is <0.5 and CSF protein level is >100 
mg/dL. The CEP TB patients reported here may represent a 
severe part of the continuum of TB meningitis or may rep-
resent a distinct encephalitic subset with atypical features.
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